TranscendAP has secured venture funding to accelerate its AI-powered accounts payable automation platform. The company aims to capture significant market share in the mid-market segment where 90% of businesses lack effective AP automation solutions.
A Swiss startup’s smart glasses technology is making its global debut through American acquisition. The industrial AR market is heating up as specialized solutions outpace consumer offerings in rugged enterprise environments.
CVS Health has reportedly returned $31 billion to shareholders through dividends and stock buybacks over the past decade. The healthcare giant’s shareholder-focused strategy appears to be paying off with an 81% year-to-date return in 2025 following a challenging 2024.
CVS Health has reportedly returned approximately $31 billion to shareholders through cash dividends and stock repurchases over the past ten years, according to financial analysis. Sources indicate this shareholder-focused capital return strategy has contributed to one of the healthcare sector’s most dramatic turnarounds, with the stock posting an impressive 81% year-to-date gain in 2025 after experiencing a 42% decline in 2024.
Calm/Storm has finalized its €30 million second fund focused on European healthtech startups. The Vienna-based venture firm has already deployed capital into 25 companies and claims the title of Europe’s most active specialized healthtech investor.
Vienna-based venture capital firm Calm/Storm has reportedly reached final close on its €30 million second fund, according to industry reports. Sources indicate the Austrian investor has already deployed capital into 25 early-stage healthtech startups, with the majority registered within Europe at the time of investment.
Elevance Health announced third quarter net income of $1.18 billion despite increasing medical expenses across its health plans. The health insurer’s revenue grew 12.4% to $50.7 billion, driven by premium yields and Medicare Advantage growth.
Elevance Health, the nation’s second-largest health insurer, reportedly achieved $1.18 billion in net income during the third quarter, representing a 17.8% increase compared to the same period last year, according to the company’s earnings report. The performance comes amid what analysts describe as ongoing cost pressures in the healthcare sector, particularly within government-subsidized insurance programs.
Multimodal artificial intelligence is expanding beyond conventional vision and language applications to address complex global challenges. A new framework emphasizes early integration of deployment constraints and interdisciplinary collaboration. This approach could accelerate AI implementation in critical areas like healthcare, climate adaptation, and autonomous systems.
Artificial intelligence research is undergoing a significant shift toward practical implementation across diverse sectors, according to reports in Nature Machine Intelligence. While multimodal AI has traditionally focused on vision and language applications, analysts suggest the field is now expanding to incorporate broader data types and deployment considerations. This evolution aims to improve understanding, prediction, and decision-making across disciplines including healthcare, engineering, and scientific research.
Infectious Disease Experts Gather for Critical Dialogue on Healthcare’s Future Thousands of infectious disease specialists are converging in Atlanta this…
